Home › Funds › PRICE T ROWE ASSOCIATES INC /MD/ › GILD

PRICE T ROWE ASSOCIATES INC /MD/ position in GILD

GILEAD SCIENCES INC · Health Care

PRICE T ROWE ASSOCIATES INC /MD/ reported holding 27,664,121 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$4.12B, representing 0.42% of its reported portfolio and ranking #38 among its reported holdings. PRICE T ROWE ASSOCIATES INC /MD/ has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)27.66M sh
Reported value held$4.12B
Portfolio Weight0.42%
First reportedQ3 2023
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How PRICE T ROWE ASSOCIATES INC /MD/'s GILD position evolved

PRICE T ROWE ASSOCIATES INC /MD/ first disclosed a stake in GILD in Q3 2023 at 2,270,526 shares (US$170.2M). The position peaked in Q3 2026 at 27,664,121 shares, worth US$4.12B. Across 13 filings, PRICE T ROWE ASSOCIATES INC /MD/ increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 27,664,121 shares valued at US$4.12B — a reduction of -2,332,573 shares quarter over quarter.. Notable position changes include a 315% increase in Q1 2025 (shares were roughly flat over the following quarter), a 60% increase in Q2 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.27M $170.15M New
Q4 2023 2.82M $228.57M Add
Q1 2024 2.49M $182.58M Reduce
Q2 2024 2.85M $195.23M Add
Q3 2024 3.35M $280.71M Add
Q4 2024 3.55M $327.61M Add
Q1 2025 14.70M $1.65B Add
Q2 2025 23.59M $2.62B Add
Q3 2025 26.50M $2.94B Add
Q4 2025 27.70M $3.40B Add
Q1 2026 26.25M $3.66B Reduce
Q2 2026 30.00M $3.79B Add
Q3 2026 27.66M $4.12B Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 33 other funds we track also report a position in GILD — the largest reported positions include BlackRock Inc (US$18.67B), Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has PRICE T ROWE ASSOCIATES INC /MD/ held GILD?

PRICE T ROWE ASSOCIATES INC /MD/ has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is PRICE T ROWE ASSOCIATES INC /MD/'s current position in GILD?

As of Q3 2026, PRICE T ROWE ASSOCIATES INC /MD/ holds 27.66M shares of GILD (GILEAD SCIENCES INC), valued at $4.12B, representing 0.42% of its reported portfolio and ranking #38.

Has PRICE T ROWE ASSOCIATES INC /MD/ been buying or selling GILD?

In the latest 13F filing (Q3 2026), PRICE T ROWE ASSOCIATES INC /MD/ reduced its position in GILD. The position peaked in Q3 2026 at 27.66M shares.

Which other funds hold GILD?

Other major institutional holders of GILD include BlackRock Inc, Fidelity Management & Research (FMR), Invesco Ltd, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.